MEDF — Medfield Diagnostics AB Balance Sheet
0.000.00%
Last trade - 00:00- SEK17.06m
- SEK9.95m
- SEK0.71m
Annual balance sheet for Medfield Diagnostics AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | SAS | SAS | SAS | SAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 18.6 | 6.59 | 10.1 | 9.7 | 7.11 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.842 | 0.513 | 0.59 | 3.34 | 0.765 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 21.4 | 9.03 | 12.9 | 15.5 | 11.9 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Total Assets | 61.3 | 55.5 | 67 | 76.6 | 77 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 6.64 | 3.74 | 3.69 | 4.03 | 3.23 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 6.64 | 3.74 | 3.69 | 4.03 | 3.23 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 54.6 | 51.8 | 63.3 | 72.6 | 73.8 |
| Total Liabilities & Shareholders' Equity | 61.3 | 55.5 | 67 | 76.6 | 77 |
| Total Common Shares Outstanding |